Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

INTRODUCTION: Non-infectious uveitis include a heterogeneous group of sight-threatening and incapacitating conditions. Their correct management sometimes requires the use of immunosuppressive drugs (ISDs), prescribed in monotherapy or in combination. Several observational studies showed that the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Ana Belen, Lopez-Picado, Amanda, Calamia, Valentina, Carreño, Ester, Cocho, Lidia, Cordero-Coma, Miguel, Fonollosa, Alex, Francisco Hernandez, Felix M, Garcia-Aparicio, Angel, Garcia-Gonzalez, Javier, Mondejar, Jose Juan, Lojo-Oliveira, Leticia, Martínez-Costa, Llucí, Munoz, Santiago, Peiteado, Diana, Pinto, Jose Antonio, Rodriguez-Lozano, Beatriz, Pato, Esperanza, Diaz-Valle, David, Molina, Elena, Tebar, Luis Alberto, Rodriguez-Rodriguez, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943738/
https://www.ncbi.nlm.nih.gov/pubmed/35318229
http://dx.doi.org/10.1136/bmjopen-2021-051378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943738/
https://www.ncbi.nlm.nih.gov/pubmed/35318229
http://dx.doi.org/10.1136/bmjopen-2021-051378

Ejemplares similares